Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm

IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced today that the global independent research and analysis firm Everest Group® has named IQVIA a “front-runner generative AI leader” for the life sciences industry in its recent report, “AI-deas to Action: Operationalizing Generative AI in Life Sciences.”

IQVIA was the only clinical research organization to receive the highest ranking of front-runner in the report, which measures the value impact of end-to-end generative AI capabilities for 15 carefully selected broad-based AI companies, CROs and life sciences specialists and niche firms. IQVIA is also the only CRO with a dedicated technology business unit to receive this designation.

“By striving for operational excellence and emphasizing the need for responsible AI governance, IQVIA is taking a thoughtful approach to its generative AI strategy, scaling select use cases from concept to deployment to maximize value across the stages of the product life cycle,” said Aastha Malik, practice director, Everest Group.

The report ranks IQVIA among five front-runners and says it showed industry leadership in its innovative strategic integrations of generative AI capabilities through various stages of research and development that help enable new ways of working. This includes several IQVIA Healthcare-grade AI® solutions to identify nuances in the patient journey for improved clinical trial design, enhanced product commercialization strategies with deeper provider engagement analytics and precise market access insights.

“Today’s life sciences and healthcare organizations are looking to balance AI innovation with continuous service delivery at high standards, striving for operational excellence,” said Harietta Eleftherochorinou, vice president, AI Strategy and Operations, IQVIA. “The pace of AI advancement is extremely fast, making it important to implement AI with effective governance and drive tangible results while incentivizing for AI experimentation and keeping up to date with emerging AI technologies. With Healthcare-grade AI as our cornerstone for privacy, quality and trust, and building on the insights from over a decade of AI solutions in the market, we are systematic in identifying the areas where AI makes a real difference and moving effectively from AI ideas to operationalization to create real-world value for our customers and their patients.”

IQVIA is gaining recognition for its ability to drive innovation and operational efficiency throughout the R&D life cycle. Earlier this year, IQVIA AI Assistant, an interactive tool to revolutionize insight generation for the healthcare and life sciences industries, was recognized with the PM360 Innovation Award in the AI Category.

About Everest Group

Everest Group is a leading global research firm helping business leaders make confident decisions. It guides clients through today’s market challenges and strengthens their strategies by applying contextualized problem-solving to their unique situations. This drives maximized operational and financial performance and transformative experiences. The Everest Group’s deep expertise and tenacious research focused on technology, business processes and engineering through the lenses of talent, sustainability and sourcing deliver precise and action-oriented guidance. Find further details and in-depth content at www.everestgrp.com.

About IQVIA

IQVIA (NYSE: IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.